Lafayette, Indiana Clinical Trials

Adenocarcinoma

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Horizon Oncology Research, Inc Updated

A clinical research study for the treatment of Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Gastric Adenocarcinoma or Colorectal Adenocarcinoma (CRC)

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Breast Cancer

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Chronic Back Pain

Research Site

Low Back Pain Research Studies

Chronic Lymphocytic Leukemia

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

View More »

Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Horizon Oncology Research, Inc

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Chronic Pain

Lafayette Clinical Research Group

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Colorectal Cancer

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Site Reference ID/Investigator# 138022

A Phase 1 clinical study for patients with Advanced Solid Tumors

Digestive System Neoplasms

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Heart Failure

Research Site

Patients are needed to participate in a clinical research study of Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg and Placebo

Leukemia

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

View More »

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Horizon Oncology Research, Inc

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Lower Back Pain

Research Site

Low Back Pain Research Studies

Lymphocytic Leukemia, Chronic

Indiana University Health Arnett Inc

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Lymphoma

Research Site

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Horizon Bio Advance

A clinical trial seeking patients for a research study for the treatment of Diffuse Large B Cell Lymphoma

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of B-Cell Lymphoma

Horizon Oncology Research, Inc.

A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin

Lymphoma, B-Cell

Research Site

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Horizon Bio Advance

A clinical trial seeking patients for a research study for the treatment of Diffuse Large B Cell Lymphoma

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of B-Cell Lymphoma

Multiple Myeloma

IU Health Arnett Cancer Center

A clinical trial to evaluate treatments for patients with Multiple Myeloma

Myelofibrosis

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Neoplasms

Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Non-Hodgkin's Lymphoma

Horizon Oncology Research, Inc.

A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin

Non-Small Cell Lung Cancer

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Research Site

A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies

Horizon Oncology

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer

Ovarian Cancer

Horizon BioAdvance

A clinical trial to evaluate treatments using EC1456 and EC20 for patients with advanced solid tumors

Pancreatic Cancer

Indiana University Health Arnett Hospital

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Solid Tumors

Horizon BioAdvance

A clinical trial to evaluate treatments using EC1456 and EC20 for patients with advanced solid tumors

Squamous Cell Carcinoma

Research Site

A clinical trial to evaluate treatments using MM-121, Docetaxel and Pemetrexed for patients

Thromboembolism

Research Site

Patients are needed to participate in a clinical research study of Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg and Placebo